Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers about the list rates of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. The offer has https://kethek.com/